NICE Notification Templates

Please note that these templates have been superseded by Blueteq.  This page will remain live until Blueteq has been fully implemented.

Adalimumab, etanercept, infliximab, rituximab, abatacept, golimumab tocilizumab for RA after failure TNF inhibitor TAG 195 TAG 198 TAG 225[pdf] 45KB
Adalimumab and etanercept for ankylosing spondylitis TAG 143[pdf] 40KB
Adalimumab for the treatment of adults with psoriasis TAG 146[pdf] 37KB
Adalimumab, etanercept, infliximab, Golimumab and Certolizumab pegol for the treatment of rheumatoid arthritis TAG 130, TAG 186, TAG 225 [pdf] 40KB
Aflibercept for treatment of age related macular degeneration TAG 294 [pdf] 120KB
Aflibercept for visual impairment caused by macular oedema secondary to central retinal vein occlusion TAG 305 [pdf] 191KB
Alitretinoin for the treatment of severe chronic hand eczema TAG 177[pdf] 31KB
Apixaban for preventing stroke and systemic embolism in people with non valvular AF TAG 275 [pdf] 70KB
Policy for the commissioning of treatments with Botulinum Toxin Type A and B[pdf] 22KB
Continuous positive airway pressure for obstructive sleep apnoea or hypopnea syndrome TAG 139 [pdf] 107KB
Continuous subcutaneous insulin infusion for diabetes mellitus TAG 151[pdf] 39KB
Denosumab for the secondary prevention of fragility fracture in postmenopausal women TAG 204[pdf] 78KB
Dexamethasone intravitreal implant - macular degeneration sec retinal vein occlusion TAG 229 [pdf] 111KB
Dronedarone for the treatment of non-permanent AF TAG 197[pdf] 36KB
Eltrombopag for treatment of chronic immune (idiopathic) thrombocytopenic pupura TAG 293 [pdf] 112KB
Etanercept for the treatment of adults with psoriasis TAG 103[pdf] 38KB
Etanercept, infliximab golimumab and adalimumab for treatment psoriatic arthritis TAG 199, TAG 200 [pdf] 120KB
Fluocinolone, acetone, intravitreal implant for treating chronic diabetic macular oedema TAG 301 [pdf] 113KB
Infliximab for acute exacerbations ulcerative colitis TAG 163[pdf] 25KB
Infliximab and adalimumab for the treatment of Crohn's disease TAG 187[pdf] 44KB
Infliximab for the treatment of adults with psoriasis TAG 134[pdf] 38KB
Ivabradine for treating chronic heart failure TAG 267 [pdf] 116KB
Natalizumab for treatment of adults with highly active relapsing- remitting multiple sclerosis TAG 127 [pdf] 102KB
Ocriplasmin for treating vetromacular traction TAG 297 [pdf] 114KB  
Prasgugrel for treatment of acute coronary syndromes with percutaneous coronary intervention TAG 182 [pdf] 107KB
Ranibizumab for the treatment of macular oedema secondary to retinal vein occlusion TAG 283[pdf] 255KB
Ranibizumab for the treatment of age-related macular degeneration TAG 155[pdf] 41KB
Ranibizumab for the treatment of diabetic macular oedema TAG 274[pdf] 70KB
Ranibizumab for treating choroidal neovascularisation associated with pathological myopia TAG 298 [pdf] 112KB
Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement adults TAG 170[pdf] 25KB
Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura TAG 221[pdf] 33KB
Somatropin (human growth hormone) for adults with growth hormone deficiency TAG 64[pdf] 33KB
Somatropin (human growth hormone) for treatment in children TAG 188 [pdf] 107KB
Teriflunomide for treating relapsing - remitting multiple sclerosis TAG 303 [pdf] 112KB 
Teriparatide for secondary prevention osteoporotic fragility fractures postmenopausal women TAG 161 [pdf] 108KB
Ticagrelor for the treatment of acute coronary syndromes TAG 236[pdf] 38KB
Ustekinumab for the treatment of adults with moderate to severe psoriasis TAG 180[pdf] 39KB